Aditya Birla Sun Life Quant Fund

An open ended equity scheme following Quant based investment themessss

July 2026

Equity Scheme
Investment Objective
The investment objective of the Scheme is to generate long term capital appreciation by investing in equity and equity related securities based on quant model theme.The Scheme does not guarantee/indicate any returns.There is no assurance that the objective of the Scheme will be achieved.
Fund Category: Thematic (Equity)
Fund Snapshot
Date of Allotment : Jun 28, 2024
Benchmark: Nifty 200 TRI
Fund Manager - Mr. Harish Krishnan
Managing the Fund Since: June 28, 2024
Experience in Managing the Fund: 2.1 Years
Fund Manager - Mr. Kartikeya Singh
Managing the Fund Since: May 13, 2026
Experience in Managing the Fund: 0.2 Years
SIP:
Monthly: Minimum ₹ 500/- and in multiples of ₹ 1/-
thereafter
Application Amount for fresh subscription:
₹ 500 (plus in multiplies of ₹ 1)
Minimum Additional Investment:
₹ 500 (plus in multiplies of ₹ 1)
Load Structure (as % of NAV) (Incl. for SIP)
Entry Load: NIL
Exit Load: For redemption/switch-out of units on or
before 90 days from the date of allotment:
0.50% of applicable NAV. For
redemption/switch-out of units after 90
days from the date of allotment: Nil.
Count of Securities: 41
AUM as on July 31, 2026 (in ₹Crore)
Month End AUM 2,037.27
Monthly Average AUM 2,027.31
Base Expense Ratio (BER)
Regular 1.76%
Direct 0.60%
BER excludes brokerage incurred towards execution of trades, transaction cost & statutory levies as applicable to investors.
NAV as on July 31, 2026
Regular Growth 10.27
Regular IDCW$ 10.26
Direct Growth 10.59
Direct IDCW$ 10.58
$Income Distribution cum capital withdrawal
Valuation Parameters
Average P/E 34.41
Average P/BV 8.67
Average Dividend Yield 1.05
Top 10 Sectoral Contribution (in %)
Market Capitalisation
Rating Profile of Portfolio
Portfolio Holdings as on July 31, 2026
( • Top Ten Holdings - Issuerwise)
Sector/Issuer Name
% of
Total AUM
% of
Derivatives
% of
Net AUM
Equity & Equity Related      
Pharmaceuticals & Biotechnology     19.42%
● Torrent Pharmaceuticals Ltd.     4.42%
● Sun Pharmaceutical Industries Ltd.     3.54%
● Laurus Labs Ltd.     3.37%
Glenmark Pharmaceuticals Ltd.     2.69%
Lupin Ltd.     2.67%
Zydus Lifesciences Ltd.     1.83%
Alkem Laboratories Ltd.     0.90%
Banks     11.49%
● Federal Bank Ltd.     4.19%
● State Bank of India     3.46%
Bank of Maharashtra     2.15%
Bank of Baroda     1.69%
Industrial Products     11.15%
Cummins India Ltd.     2.92%
AIA Engineering Ltd.     2.58%
Polycab India Ltd.     2.54%
APL Apollo Tubes Ltd.     2.11%
KEI Industries Ltd.     1.01%
Healthcare Services     7.02%
● Apollo Hospitals Enterprise Ltd.     4.17%
Aster DM Quality Care Ltd.     2.86%
Cement & Cement Products     6.60%
● Grasim Industries Ltd.     3.72%
UltraTech Cement Ltd.     2.88%
Ferrous Metals     6.58%
Tata Steel Ltd.     3.06%
Jindal Steel Ltd.     2.70%
Steel Authority of India Ltd.     0.83%
Agricultural Food & other Products     4.79%
● Marico Ltd.     4.79%
Automobiles     4.75%
Eicher Motors Ltd.     2.78%
Ather Energy Ltd.     1.05%
Bajaj Auto Ltd.     0.93%
Food Products     4.33%
● Nestle India Ltd.     4.33%
Non - Ferrous Metals     4.06%
● Hindalco Industries Ltd.     3.33%
National Aluminium Co. Ltd.     0.72%
Finance     3.85%
L&T Finance Ltd.     2.51%
Shriram Finance Ltd.     1.33%
Diversified Metals     2.49%
Vedanta Ltd.     2.49%
Auto Components     2.49%
Bharat Forge Ltd.     2.49%
Chemicals & Petrochemicals     2.32%
Navin Fluorine International Ltd.     2.32%
Electrical Equipment     2.28%
Bharat Heavy Electricals Ltd.     2.28%
Beverages     2.03%
Radico Khaitan Ltd     2.03%
Retailing     1.61%
FSN E-Commerce Ventures Ltd.     1.61%
Transport Services     1.41%
Delhivery Ltd.     1.41%
Minerals & Mining     0.98%
NMDC Ltd.     0.98%
PREFERRED STOCK     0.06%
TVS Motor Company Ltd.     0.06%
Net Cash and Cash Equivalent     0.28%
Grand Total     100.00%

Miscellaneous includes securities with exposure of less than 0.01%

Product Label
Scheme Name
Aditya Birla Sun Life Quant Fund
An Open ended equity scheme following Quant based investment theme
This product is suitable for investors who are seeking*:
  • Long term Capital Appreciation
  • Investment in equity and equity related instruments selected based on quant model
Risk-o-meter
Benchmark Risk-o-meter
Nifty 200 TRI

*Investors should consult their financial advisors if in doubt whether the product is suitable for them.